| Primary |
| Smoking Cessation Therapy |
33.0% |
| Drug Use For Unknown Indication |
27.7% |
| Product Used For Unknown Indication |
16.2% |
| Ex-tobacco User |
12.1% |
| Ex-smoker |
3.1% |
| Drug Withdrawal Maintenance Therapy |
2.3% |
| Depression |
1.4% |
| Hypertension |
0.8% |
| Epilepsy |
0.7% |
| Tobacco User |
0.6% |
| Supplementation Therapy |
0.5% |
| Anxiety |
0.3% |
| Asthma |
0.3% |
| Anxiety Disorder |
0.2% |
| Multiple Sclerosis |
0.2% |
| Spinal Column Stenosis |
0.2% |
| Arthritis |
0.1% |
| Bipolar Disorder |
0.1% |
| Blood Cholesterol Increased |
0.1% |
| Blood Pressure |
0.1% |
|
| Nicotine Dependence |
14.8% |
| Application Site Pruritus |
12.1% |
| Nausea |
10.4% |
| Vomiting |
6.9% |
| Pain In Extremity |
5.9% |
| Application Site Rash |
4.7% |
| Hypersensitivity |
4.6% |
| Drug Ineffective |
4.3% |
| Application Site Erythema |
3.7% |
| Application Site Swelling |
3.4% |
| Application Site Reaction |
3.4% |
| Tremor |
3.4% |
| Application Site Urticaria |
3.1% |
| Intentional Drug Misuse |
3.1% |
| Rash |
3.1% |
| Insomnia |
3.0% |
| Malaise |
2.8% |
| Nightmare |
2.6% |
| Application Site Irritation |
2.5% |
| Abnormal Dreams |
2.2% |
|
| Secondary |
| Smoking Cessation Therapy |
37.4% |
| Ex-tobacco User |
36.9% |
| Product Used For Unknown Indication |
10.5% |
| Drug Use For Unknown Indication |
3.9% |
| Drug Withdrawal Maintenance Therapy |
1.5% |
| Depression |
1.4% |
| Tobacco Abuse |
1.2% |
| Parkinson's Disease |
1.0% |
| Prophylaxis |
1.0% |
| Biliary Cirrhosis |
0.7% |
| Ex-smoker |
0.7% |
| Obsessive Thoughts |
0.7% |
| Foetal Exposure During Pregnancy |
0.5% |
| Hiv Test Positive |
0.5% |
| Arthritis |
0.3% |
| Colitis |
0.3% |
| Hernia |
0.3% |
| Ill-defined Disorder |
0.3% |
| Infection |
0.3% |
| Tobacco User |
0.3% |
|
| Nicotine Dependence |
23.2% |
| Intentional Drug Misuse |
9.6% |
| Vomiting |
7.7% |
| Drug Ineffective |
6.9% |
| Nausea |
6.3% |
| Application Site Pruritus |
5.2% |
| Palpitations |
4.6% |
| Nightmare |
4.0% |
| Hypersensitivity |
3.3% |
| Application Site Erythema |
2.9% |
| Pain In Extremity |
2.9% |
| Stomach Discomfort |
2.9% |
| Application Site Rash |
2.7% |
| Throat Irritation |
2.7% |
| Urticaria |
2.7% |
| Abnormal Dreams |
2.5% |
| Malaise |
2.5% |
| Rash |
2.5% |
| Weight Increased |
2.5% |
| Application Site Urticaria |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
47.7% |
| Pain |
12.0% |
| Drug Use For Unknown Indication |
3.6% |
| Multiple Sclerosis |
3.6% |
| Smoking Cessation Therapy |
3.3% |
| Anxiety |
2.7% |
| Non-small Cell Lung Cancer |
2.7% |
| Depression |
2.4% |
| Headache |
2.4% |
| Hypertension |
2.4% |
| Muscle Spasms |
2.4% |
| Bronchitis |
2.1% |
| Wheezing |
2.1% |
| Convulsion |
1.8% |
| Head And Neck Cancer |
1.8% |
| Oral Candidiasis |
1.8% |
| Thrombosis Prophylaxis |
1.5% |
| Electrolyte Substitution Therapy |
1.2% |
| Facial Pain |
1.2% |
| General Symptom |
1.2% |
|
| Vomiting |
10.0% |
| Cryptococcal Fungaemia |
6.7% |
| Meningitis Cryptococcal |
6.7% |
| Pain |
6.7% |
| Pneumonia |
6.7% |
| Pregnancy |
6.7% |
| Pulmonary Embolism |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| White Blood Cell Count Increased |
6.7% |
| Abdominal Pain Upper |
3.3% |
| Cardiac Arrest |
3.3% |
| Chest Discomfort |
3.3% |
| Cystitis |
3.3% |
| Dementia |
3.3% |
| Depression |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Drug Ineffective |
3.3% |
| Drug Toxicity |
3.3% |
| Drug Withdrawal Syndrome |
3.3% |
| Dystonia |
3.3% |
|
| Interacting |
| Smoking Cessation Therapy |
100.0% |
|
| Drug Interaction |
33.3% |
| Hallucination |
33.3% |
| Nightmare |
33.3% |
|
